RAD51 and esophageal squamous cell carcinoma: In addition, we observed that RAD51 was commonly over-expressed in human ESCC tissues, indicating that it is necessary to downregulate RAD51 to achieve high radio- or chemotherapeutic efficacy of ESCC in clinic, because overexpression of RAD51 is known to confer radio- and chemoresistance.